ASSOCIATION BETWEEN DAILY GLUCOSE FLUCTUATION AND CORONARY PLAQUE PROPERTIES IN PATIENTS RECEIVING LIPID-LOWERING THERAPY ASSESSED BY CONTINUOUS GLUCOSE MONITORING AND OPTICAL COHERENCE TOMOGRAPHY: A PROSPECTIVE OBSERVATIONAL STUDY  by Kuroda, Masaru et al.
TCT@ACC-i2: Interventional Cardiology
A1851
JACC March 17, 2015
Volume 65, Issue 10S
assoCiation between daily GlUCose FlUCtUation and Coronary plaqUe properties 
in patients reCeivinG lipid-lowerinG therapy assessed by ContinUoUs GlUCose 
monitorinG and optiCal CoherenCe tomoGraphy: a prospeCtive observational stUdy
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Pharmacotherapy and Complex Coronary Interventions
Abstract Category: 36. TCT@ACC-i2: IVUS and Intravascular Physiology
Presentation Number: 2103-269
Authors: Masaru Kuroda, Toshiro Shinke, Kazuhiko Sakaguchi, Hiromasa Otake, Tomofumi Takaya, Yushi Hirota, Tsuyoshi Osue, 
Hiroto Kinutani, Akihide Konishi, Hachidai Takahashi, Daisuke Terashita, Kenzo Uzu, Yuto Shinkura, Natsuko Tahara, Koji Kuroda, Daiji 
Kashiwagi, Keisuke Nagasawa, Ken-ichi Hirata, Kobe University Graduate School of Medicine., Kobe, Japan
background: This study aimed to investigate the association between glucose fluctuation and coronary plaque morphology in coronary 
artery disease (CAD) patients pretreated with lipid-lowering therapy.
methods: This prospective study enrolled 45 consecutive CAD patients receiving lipid-lowering therapy who were referred for 
percutaneous coronary intervention. Glucose fluctuation, expressed as the mean amplitude of glycemic excursion (MAGE), and time in 
hypoglycemia were determined by continuous glucose monitoring. Morphological feature of plaques were evaluated by optical coherence 
tomography. Lipid index (LI) (mean lipid arc × lipid length), fibrous cap thickness (FCT) and the prevalence of thin-cap fibroatheroma 
(TCFA) were assessed in both culprit and non-culprit lesions.
results: A total of 95 lesions were evaluated. MAGE was correlated with LI and FCT (Figure). Longer time in hypoglycemia was 
significantly correlated with thinner FCT (r = -0.281, P < 0.001). Multiple linear regression analysis showed that MAGE had the strongest 
effect on LI and FCT (standardized coefficient β = 0.523 and -0.520, respectively, both P < 0.001). Multiple logistic analysis identified 
MAGE as the only independent predictor of the presence of TCFA (odds ratio 1.021; 95% confidence interval 1.006-1.038, P = 0.008).
Conclusion:  Glucose fluctuation including hypoglycemia may impact the formation of lipid-rich plaques and thinning of the fibrous cap in 
CAD patients receiving lipid-lowering therapy.
 
